Infinity Pharmaceuticals | INFI - Current Assets


Infinity Pharmaceuticals reported $19.91M in Current Assets for its fiscal quarter ending in June of 2023.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Alterity Therapeutics Limited AUD 27.05M 6.16M Jun/2023
Amgen USD 29.06B 1.17B Dec/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Cipla INR 249.18B 16.3B Sep/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 88.92M 8.72M Sep/2025
CSL USD 11.85B 542M Jun/2025
Eisai JPY 840.88B 50.18B Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
Grifols EUR 6.28B 92.48M Sep/2025
Incyte USD 5.02B 746.01M Dec/2025
Infinity Pharmaceuticals USD 19.91M 8.46M Jun/2023
Ionis Pharmaceuticals USD 2.52B 58.16M Sep/2025
J&J USD 55.62B 1.01B Dec/2025
Novartis USD 28.2B 2.26B Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Plus Therapeutics USD 9.83M 1.75M Dec/2023
Roche Holding CHF 38.73B 3.03B Dec/2025
TG Therapeutics USD 599.76M 64.2M Sep/2025